Charpidou A, Mani M, Kokkotou E, Stournara L, Stathelou L et al (2024) Molecular diagnostics and treatment patterns in metastatic non-small cell lung cancer patients: real world evidence from Greece: LACHESIS study. Anticancer Res 44(5):2063–2072

Article  PubMed  Google Scholar 

Conroy M, Naidoo J (2022) Immune-related adverse events and the balancing act of immunotherapy. Nat Commun 13(392):1–4

Google Scholar 

Yin Q, Wu L, Han L, Zheng X, Tong R (2023) Immune-related adverse events of immune checkpoint inhibitors: a review. Front Immunol. https://doi.org/10.3389/fimmu.2023.1167975

Article  PubMed  PubMed Central  Google Scholar 

Barron CC, Stefanova J, Cha Y, Elsolh K, Zereshkian A et al (2023) Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review. J Immunother Cancer 11(e006500):1–7

Google Scholar 

Reynolds G (2023) Rheumatic complications of checkpoint inhibitors: lessons from autoimmunity. Immunol Rev 318:51–60

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417

Article  PubMed  Google Scholar 

Thomas A, Jayan A, Chang Y, Svetgoff R, Datar S et al (2022) Pembrolizumab-associated acral necrosis and esophageal necrosis. Curr Probl Cancer: Case Rep 8:100193

Google Scholar 

Kefas J, Harwood C, Lewis MJ, Szlosarek P (2022) Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma. BMC Rheumatol 6(10):1–5

Google Scholar 

O’Connor P, Laury R, Bhadbhade P, Khan Q, Williamson S (2020) Acral vascular syndrome during an immune checkpoint inhibitor. BMJ Case Rep 13(e233463):1–6

Google Scholar 

Zenati N, Charles J, Templier I, Blaise S (2019) Ischémie digitale avec ulcération pulpaire sous ipilimumab/ Digital ischaemia with fingertip ulcers during ipilimumab therapy. Rev Mal Respir Actual 2834:1–5

Google Scholar 

Khaddour K, Singh V, Shayuk M (2019) Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review. BMC Cancer 19(449):1–6

Google Scholar 

Franco F, Mendez M, Gutierrez L, Sanz J, Calvo V et al (2019) Nivolumab-associated digital small-vessel vasculitis in a patient with an advanced renal cell carcinoma. Immunotherapy 11(5):379–384

Article  CAS  PubMed  Google Scholar 

Padda A, Schiopu E, Sovich J, Ma V, Alva A et al (2018) Ipilimumab induced digital vasculitis. J Immunother Cancer 6(12):1–5

Google Scholar 

Comont T, Sibaud V, Mourey L, Cougoul P, Beyne-Rauzy O (2018) Immune checkpoint inhibitor-related acral vasculitis. J Immunother Cancer 6(120):1–3

Google Scholar 

Gambichler T, Strutzmann S, Tannapfel A, Susok L (2017) Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. BMC Cancer 17(327):1–5

Google Scholar 

Le Burel S, Champiat S, Routier E, Aspeslagh S, Albiges L et al (2017) Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2016-210820

Article  PubMed  Google Scholar 

Kim ST, Tayar J, Trinh VA, Suarez-Almazor M, Garcia S et al (2017) Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis 76(12):2061

Article  PubMed  Google Scholar 

Badran YR, Cohen JV, Brastianos PK, Parikh AR, Hong TS et al (2019) Concurrent therapy with immune checkpoint inhibitors and TNFαblockade in patients with gastrointestinal immune-related adverse events. J Immunother Cancer 7(1):226

Article  PubMed  PubMed Central  Google Scholar 

Lord JD, Hackman RC, Moklebust A, Thompson JA, Higano CS et al (2010) Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells. Dig Dis Sci 55(5):1396

Article  PubMed  Google Scholar 

Ceeraz S, Nowak EC, Burns CM, Noelle RJ (2014) Immune checkpoint receptors in regulating immune reactivity in rheumatic disease. Arthritis Res Ther 16(5):469

Article  PubMed  PubMed Central  Google Scholar 

Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I et al (2010) The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum 62(7):1870–1880

Article  CAS  PubMed  Google Scholar 

Liu C, Jiang J, Gao L, Wang X, Hu X et al (2015) Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways. Arthritis Res Ther 17:340

Article  PubMed  PubMed Central  Google Scholar 

Pontarini E, Verstappen GM, Grigoriadou S, Kroese FGM, Bootsma H et al (2020) Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers. Clin Exp Rheumatol 38(126):222–227

PubMed  Google Scholar 

Moneim A, Hosny MM, Omard HH, Abdelnabya MM, Fouad MM et al (2023) Relative CTLA-4, PTPN-22, and interleukin 37 mRNA expressions in patients with lupus nephritis. Reumatol Clín 19(4):180–187

Article  Google Scholar